Skip to Content
Merck
CN
All Photos(1)

Documents

BP1248

Candesartan cilexetil

British Pharmacopoeia (BP) Reference Standard

Sign Into View Organizational & Contract Pricing
All Photos(1)
Synonym(s):
2-ethoxy-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-Benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester, TCV 116, TCY 116
Empirical Formula (Hill Notation):
C33H34N6O6
CAS Number:
145040-37-5
Molecular Weight:
610.66
MDL number:
MFCD00871371
UNSPSC Code:
41116107
NACRES:
NA.24

grade

pharmaceutical primary standard

Quality Level

100

API family

candesartan

form

solid

shelf life

limited shelf life, expiry date on the label

manufacturer/tradename

BP

application(s)

pharmaceutical
pharmaceutical small molecule

format

neat

storage temp.

2-8°C

SMILES string

CCOc1nc2cccc(C(=O)OC(C)OC(=O)OC3CCCCC3)c2n1Cc4ccc(cc4)-c5ccccc5-c6nnn[nH]6

InChI

1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)

InChI key

GHOSNRCGJFBJIB-UHFFFAOYSA-N

Gene Information

human ... AGTR1(185)

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Candesartan cilexetil BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Candesartan Tablets

    • Biochem/physiol Actions

    Candesartan cilexetil is the prodrug form of the potent angiotensin II receptor antagonist, candesartan. The prodrug is cleaved by esterases within the intestine to liberate the active molecule.

    Packaging

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    Other Notes

    Sales restrictions may apply.

    related product

    Product No.
    Description
    Pricing

    Y0001388

    Candesartan cilexetil, European Pharmacopoeia (EP) Reference Standard

    Y0001387

    Candesartan cilexetil for peak identification, European Pharmacopoeia (EP) Reference Standard

    Y0001389

    Candesartan cilexetil for system suitability, European Pharmacopoeia (EP) Reference Standard

    1087803

    Candesartan cilexetil, United States Pharmacopeia (USP) Reference Standard

    1087814

    Candesartan cilexetil Related Compound A, United States Pharmacopeia (USP) Reference Standard

    1087825

    Candesartan cilexetil Related Compound B, United States Pharmacopeia (USP) Reference Standard

    1087847

    Candesartan cilexetil Related Compound D, United States Pharmacopeia (USP) Reference Standard

    1087869

    Candesartan cilexetil Related Compound F, United States Pharmacopeia (USP) Reference Standard

    1087870

    Candesartan cilexetil Related Compound G, United States Pharmacopeia (USP) Reference Standard

    PHR1854

    Candesartan Cilexetil, Pharmaceutical Secondary Standard; Certified Reference Material

    PHR2035

    Candesartan cilexetil impurity C, Pharmaceutical Secondary Standard; Certified Reference Material

    PHR2021

    Candesartan Cilexetil Related Compound G, Pharmaceutical Secondary Standard; Certified Reference Material

    PHR2036

    Candesartan Cilexetil Impurity E, Pharmaceutical Secondary Standard; Certified Reference Material

    PHR2020

    Candesartan Cilexetil Related Compound F, Pharmaceutical Secondary Standard; Certified Reference Material

    PHR2018

    Candesartan Cilexetil Related Compound B, Pharmaceutical Secondary Standard; Certified Reference Material

    PHR2022

    Candesartan Cilexetil Impurity I, Pharmaceutical Secondary Standard; Certified Reference Material

    PHR2019

    Candesartan Cilexetil Related Compound D, Pharmaceutical Secondary Standard; Certified Reference Material

    PHR2017

    Candesartan Cilexetil Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

    BP1249

    Candesartan Cilexetil Impurity Standard, British Pharmacopoeia (BP) Reference Standard

    Pictograms

    Health hazard
    GHS08

    Signal Word

    Danger

    Hazard Statements

    H360D,H373

    Hazard Classifications

    Repr. 1B - STOT RE 2 Oral

    Target Organs

    Kidney,Blood

    WGK

    WGK 3

    Flash Point(F)

    Not applicable

    Flash Point(C)

    Not applicable

    Certificates of Analysis (COA)

    Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service